• If you ever wonder what #ukraine is really all about and WHY the corruptors are pretending there is a war against civilians when it is actually against this!

    Look what is Verified to be located there!

    Same industry I have been doing reports on for Years and what exists in various locations and #Cabal strongholds!
    As you flip through the fully linked Facebook Frames thread you are going to find #Merck, #glaxosmithkline, #Bayer, #WorldwideClinicalTrials and various other companies I have done deep dives on over the years.

    Do you remember when in 2018. . .#Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company?

    Do you find that interesting?
    The #UkraineCrisis has to do with known "alleged" corruptors protecting their Interests!
    All from Glassdoor and located in #kiev Ukraine!
    Then take a look at the Huff Post article.
    Mainstream so not sure what the "factchecker" Overlords are going to do about that! #panic in the DS!

    See how much of this biotech parallels industry from a prior deep dive on on area ripe with the cartel, coyotes, rape trees and human trafficking.

    Hear about a foster father to roughly 20 children in the last three years and there is evidence of thousands of videos of him doing horrific things to children. Police say he had thousands of photos and videos of children, many of them involving sexual abuse.

    #Ukraine, #Biolabs, #Biotech, #Biden, #HunterBiden, #Tucson, #Kiev, #Labs, #UkraineLabs, #HunterBidenDeals, #BidenDeals, #BabyFarming, #UkraineCrisis, #Cabal, #GlobalistCorruption, #FosterCareSystem, #UkraineOrphanages, #UkraineAdoption, #NeiliaBiden, #NaomiBiden

    https://www.bitchute.com/video/CLfizW1zElVr/
    If you ever wonder what #ukraine is really all about and WHY the corruptors are pretending there is a war against civilians when it is actually against this! Look what is Verified to be located there! Same industry I have been doing reports on for Years and what exists in various locations and #Cabal strongholds! As you flip through the fully linked Facebook Frames thread you are going to find #Merck, #glaxosmithkline, #Bayer, #WorldwideClinicalTrials and various other companies I have done deep dives on over the years. Do you remember when in 2018. . .#Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company? Do you find that interesting? The #UkraineCrisis has to do with known "alleged" corruptors protecting their Interests! All from Glassdoor and located in #kiev Ukraine! Then take a look at the Huff Post article. Mainstream so not sure what the "factchecker" Overlords are going to do about that! #panic in the DS! See how much of this biotech parallels industry from a prior deep dive on on area ripe with the cartel, coyotes, rape trees and human trafficking. Hear about a foster father to roughly 20 children in the last three years and there is evidence of thousands of videos of him doing horrific things to children. Police say he had thousands of photos and videos of children, many of them involving sexual abuse. #Ukraine, #Biolabs, #Biotech, #Biden, #HunterBiden, #Tucson, #Kiev, #Labs, #UkraineLabs, #HunterBidenDeals, #BidenDeals, #BabyFarming, #UkraineCrisis, #Cabal, #GlobalistCorruption, #FosterCareSystem, #UkraineOrphanages, #UkraineAdoption, #NeiliaBiden, #NaomiBiden https://www.bitchute.com/video/CLfizW1zElVr/
    Like
    1
    0 Comments 0 Shares 4K Views
  • New York’s Washington Heights, a former convent houses a revolving stable of children who’ve been removed from their own homes by the Agency for Child Services. These children are black, Hispanic & poor. Many of their mothers had a history of drug abuse & have died. Once taken into ICC, the children become subjects of drug trials sponsored by NIAID, NICHD, in conjunction with some of the world’s largest Pharmaceutical companies – GlaxoSmithKline, Pfizer, Genentech, Chiron/Biocine & others. https://www.thegatewaypundit.com/.../wasnt-just.../...
    New York’s Washington Heights, a former convent houses a revolving stable of children who’ve been removed from their own homes by the Agency for Child Services. These children are black, Hispanic & poor. Many of their mothers had a history of drug abuse & have died. Once taken into ICC, the children become subjects of drug trials sponsored by NIAID, NICHD, in conjunction with some of the world’s largest Pharmaceutical companies – GlaxoSmithKline, Pfizer, Genentech, Chiron/Biocine & others. https://www.thegatewaypundit.com/.../wasnt-just.../...
    It Wasn’t Just Beagles and Monkeys – Fauci’s NIH Also Funded Medical Experiments on AIDS Orphans in NY City
    Angry
    2
    0 Comments 0 Shares 773 Views
  • (Jun. 05, 2021)——On Jun. 05, 1909, about 650 newspapermen from throughout the British Empire and America were brought to London, paid for by Burroughs Wellcome & Co. (now named GlaxoSmithKline), for an all-hands-on deck meeting to consolidate editorial control of the Empire by the British Pilgrims Society.
    (Jun. 05, 2021)——On Jun. 05, 1909, about 650 newspapermen from throughout the British Empire and America were brought to London, paid for by Burroughs Wellcome & Co. (now named GlaxoSmithKline), for an all-hands-on deck meeting to consolidate editorial control of the Empire by the British Pilgrims Society.
    0 Comments 0 Shares 549 Views
  • **North America Osteoporosis Treatment Market: Celltrion Healthcare Co., Ltd. Commences Phase 1 Trial of Denosumab Biosimilar to Amplify its Market Position**
    The North America osteoporosis treatment market size is expected to gain momentum by reaching USD 8.29 billion by 2027 while exhibiting a CAGR of 6.6% between 2020 and 2027. This is attributable to the increasing prevalence of osteoporosis and the growing number of government approvals for the therapeutic drugs that are propelling the demand in the North America osteoporosis treatment options. Fortune Business Insights in its latest report, titled, “North America Osteoporosis Treatment Market Size, Share &Covid-19 Impact Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral); By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies), 2020-2027.”, mentions that the market stood at USD 5.18 billion in 2019.

    Request Sample PDF Request a Sample - Osteoporosis Treatment Market Size, Share and Global Industry Trend Forecast till 2025 (https://www.fortunebusinessinsights.com/enquiry/sample/osteoporosis-treatment-market-101034)

    COVID-19 Impact: Market to Experience a Sluggish Growth at 2.3% CAGR in 2020

    The COVID-19 pandemic has led to the healthcare systems and hospitals to divert their complete focus on treating people suffering from the disease. In contrast, several elective medical procedures and osteoporosis treatment appointments have either been canceled or postponed. Based on our analysis, the market will exhibit aslow growth at 2.3% CAGR in 2020 due to the aforementioned reasons. However, the market will return to normalcy once the pandemic is over.

    Osteoporosis is a type of medical condition that occurs when the bone synthesis gets interrupted and if left unattended, often may lead to a fracture. In addition to this, the condition leads to brittle and lower density of bones and is mostly common in the older population, along with women.


    ***COMPETITIVE LANDSCAPE***
    **Collaboration between Eminent Companies to Brighten Their Market Positions**
    The market for North America is experiencing proactive competition between major companies that are collaborating with other companies to expand their product portfolio and boost sales revenue. Furthermore, other key players are adopting organic and inorganic strategies such as partnership, the introduction of novel products, and merger and acquisition that will bode well for the growth of the market for North America.
    Major companies in the Global North America Osteoporosis Treatment Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends & drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the North America Osteoporosis Treatment Industry.
    https://www.fortunebusinessinsights.com/enquiry/customization/osteoporosis-treatment-market-101034***Industry Development:***
    ·
    **August 2020** - Celltrion Healthcare Co., Ltd commenced the Phase 1 trial of Denosumab Biosimilar, a monoclonal antibody injection adopted in the management of osteoporosis. The company has invested in R&D to develop novel therapeutics solutions for the treatment of the disease.
    ***List of the Companies Profiled in the Market:***
    ·
    AbbVie Inc. (North Chicago, Illinois, U.S.)
    ·
    Eli Lilly and Company (Indianapolis, Indiana, U.S.)
    ·
    Amgen Inc. (Thousand Oaks, California, U.S.)
    ·
    F. Hoffmann-La Roche Ltd (Basel, Switzerland)
    ·
    Novartis AG (Basel, Switzerland)
    ·
    Sanofi (Paris, France)
    ·
    Pfizer Inc. (Brooklyn, New York, U.S.)
    ·
    Merck & Co., Inc. (Kenilworth, New Jersey, U.S.)
    ·
    GlaxoSmithKline plc (Brentford, U.K)
    ·
    Alcon (Geneva, Switzerland)
    ·
    Other Prominent Player
    **North America Osteoporosis Treatment Market: Celltrion Healthcare Co., Ltd. Commences Phase 1 Trial of Denosumab Biosimilar to Amplify its Market Position** The North America osteoporosis treatment market size is expected to gain momentum by reaching USD 8.29 billion by 2027 while exhibiting a CAGR of 6.6% between 2020 and 2027. This is attributable to the increasing prevalence of osteoporosis and the growing number of government approvals for the therapeutic drugs that are propelling the demand in the North America osteoporosis treatment options. Fortune Business Insights in its latest report, titled, “North America Osteoporosis Treatment Market Size, Share &Covid-19 Impact Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral); By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies), 2020-2027.”, mentions that the market stood at USD 5.18 billion in 2019. Request Sample PDF Request a Sample - Osteoporosis Treatment Market Size, Share and Global Industry Trend Forecast till 2025 (https://www.fortunebusinessinsights.com/enquiry/sample/osteoporosis-treatment-market-101034) COVID-19 Impact: Market to Experience a Sluggish Growth at 2.3% CAGR in 2020 The COVID-19 pandemic has led to the healthcare systems and hospitals to divert their complete focus on treating people suffering from the disease. In contrast, several elective medical procedures and osteoporosis treatment appointments have either been canceled or postponed. Based on our analysis, the market will exhibit aslow growth at 2.3% CAGR in 2020 due to the aforementioned reasons. However, the market will return to normalcy once the pandemic is over. Osteoporosis is a type of medical condition that occurs when the bone synthesis gets interrupted and if left unattended, often may lead to a fracture. In addition to this, the condition leads to brittle and lower density of bones and is mostly common in the older population, along with women. ***COMPETITIVE LANDSCAPE*** **Collaboration between Eminent Companies to Brighten Their Market Positions** The market for North America is experiencing proactive competition between major companies that are collaborating with other companies to expand their product portfolio and boost sales revenue. Furthermore, other key players are adopting organic and inorganic strategies such as partnership, the introduction of novel products, and merger and acquisition that will bode well for the growth of the market for North America. Major companies in the Global North America Osteoporosis Treatment Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends & drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the North America Osteoporosis Treatment Industry. https://www.fortunebusinessinsights.com/enquiry/customization/osteoporosis-treatment-market-101034***Industry Development:*** · **August 2020** - Celltrion Healthcare Co., Ltd commenced the Phase 1 trial of Denosumab Biosimilar, a monoclonal antibody injection adopted in the management of osteoporosis. The company has invested in R&D to develop novel therapeutics solutions for the treatment of the disease. ***List of the Companies Profiled in the Market:*** · AbbVie Inc. (North Chicago, Illinois, U.S.) · Eli Lilly and Company (Indianapolis, Indiana, U.S.) · Amgen Inc. (Thousand Oaks, California, U.S.) · F. Hoffmann-La Roche Ltd (Basel, Switzerland) · Novartis AG (Basel, Switzerland) · Sanofi (Paris, France) · Pfizer Inc. (Brooklyn, New York, U.S.) · Merck & Co., Inc. (Kenilworth, New Jersey, U.S.) · GlaxoSmithKline plc (Brentford, U.K) · Alcon (Geneva, Switzerland) · Other Prominent Player
    WWW.FORTUNEBUSINESSINSIGHTS.COM
    Request a Sample - Osteoporosis Treatment Market Size, Share and Global Industry Trend Forecast till 2025
    The global osteoporosis treatment market size was valued at USD 10.74 billion in 2018 and is projected to reach USD 15.08 billion by 2026, exhibiting a CAGR of 4.3% during the forecast period.
    0 Comments 0 Shares 680 Views
  • **Anti-obesity Drugs Market to Reach USD 3,421.0 Million by 2027; Increasing Adoption of Weight Management Drugs to Aid Growth, states Fortune Business Insightsâ„¢ **
    The global anti-obesity drugs market size is set to grow significantly owing to the ever-increasing prevalence of obesity among the global population, observes Fortune Business Insightsâ„¢ in its report, titled, “Anti-obesity Drugs Market Size, Share & COVID-19 Impact Analysis, By Type (Prescription Drugs and OTC Drugs), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The market size was USD 1,520.2 million in 2019 and is anticipated to reach USD 3,421.0 million by 2027, exhibiting a CAGR of 10.1% during the forecast period.
    Request Sample PDF@ Request a Sample - Anti-obesity Drugs Market Size, Share and Global Industry Trend Forecast till 2025 (https://www.fortunebusinessinsights.com/enquiry/sample/anti-obesity-drugs-market-104783)
    Healthcare Sector to Stumble amid COVID-19 Pandemic
    The healthcare sector has been the most active ever since the COVID-19 outbreak. While the pandemic has fast-tracked the development of the industry on a global scale, it has also brought numerous adversities upon the sector. These adversities include limited infrastructure in developing countries and the lack of preparedness in case of health emergencies. Key players are focusing on eliminating such challenges.
    ***Industry Developments-***
    ·
    **In December 2020, **theU.S. Food and Drug Administration (FDA) approved Saxenda, Novo Nordisk’s anti-obesity drug for the treatment of obesity in adolescents aged 12-17.
    ·
    **In February 2019, **Eisai Inc. announced that the U.S. Food and Drug Administration (FDA) had accepted its new supplemental drug application. This will update the labeling of BELVIQ, the company’s anti-obesity drug.
    ***A List of Key Manufacturers Operating In the Market Report:***
    • Novo Nordisk (Denmark, Scandinavia)
    • GlaxoSmithKline (Brentford, U.K)
    • Vivus Pharmaceuticals (California U.S)
    • Currax Pharmaceuticals LLC (New Jersey, U.S)
    • Pfizer Inc. (New York, U.S)
    • F. Hoffmann-La Roche Ltd (Basel, Switzerland)
    • Other Players
    **Anti-obesity Drugs Market to Reach USD 3,421.0 Million by 2027; Increasing Adoption of Weight Management Drugs to Aid Growth, states Fortune Business Insights™ ** The global anti-obesity drugs market size is set to grow significantly owing to the ever-increasing prevalence of obesity among the global population, observes Fortune Business Insights™ in its report, titled, “Anti-obesity Drugs Market Size, Share & COVID-19 Impact Analysis, By Type (Prescription Drugs and OTC Drugs), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The market size was USD 1,520.2 million in 2019 and is anticipated to reach USD 3,421.0 million by 2027, exhibiting a CAGR of 10.1% during the forecast period. Request Sample PDF@ Request a Sample - Anti-obesity Drugs Market Size, Share and Global Industry Trend Forecast till 2025 (https://www.fortunebusinessinsights.com/enquiry/sample/anti-obesity-drugs-market-104783) Healthcare Sector to Stumble amid COVID-19 Pandemic The healthcare sector has been the most active ever since the COVID-19 outbreak. While the pandemic has fast-tracked the development of the industry on a global scale, it has also brought numerous adversities upon the sector. These adversities include limited infrastructure in developing countries and the lack of preparedness in case of health emergencies. Key players are focusing on eliminating such challenges. ***Industry Developments-*** · **In December 2020, **theU.S. Food and Drug Administration (FDA) approved Saxenda, Novo Nordisk’s anti-obesity drug for the treatment of obesity in adolescents aged 12-17. · **In February 2019, **Eisai Inc. announced that the U.S. Food and Drug Administration (FDA) had accepted its new supplemental drug application. This will update the labeling of BELVIQ, the company’s anti-obesity drug. ***A List of Key Manufacturers Operating In the Market Report:*** • Novo Nordisk (Denmark, Scandinavia) • GlaxoSmithKline (Brentford, U.K) • Vivus Pharmaceuticals (California U.S) • Currax Pharmaceuticals LLC (New Jersey, U.S) • Pfizer Inc. (New York, U.S) • F. Hoffmann-La Roche Ltd (Basel, Switzerland) • Other Players
    WWW.FORTUNEBUSINESSINSIGHTS.COM
    Request a Sample - Anti-obesity Drugs Market Size, Share and Global Industry Trend Forecast till 2025
    The global anti-obesity drugs market size was USD 1,520.2 million in 2019. The global impact of COVID-19 has been unprecedented and staggering, with anti-obesity pharma witnessing a positive demand shock across all regions amid the pandemic.
    0 Comments 0 Shares 508 Views
  • Following the money...

    The Wuhan Chinese biological laboratory is owned by GlaxoSmithKline, which (by chance) also owns Pfizer.

    GlaxoSmithKline (accidentally) is controlled by Black Rock's financial department, which (accidentally) addresses the finances of Open Foundation Company (Soros Foundation), which (by accident)
    french manages AXA.

    Soros (accidentally) is the owner of the German Winterthur company that (accidentally) built a Chinese laboratory in Wuhan and bought by German Alliance, whose (accidentally) Vanguard is (by chance) is the shareholder of Black Rock, which (by chance) checks the central banks and manages about a third of global investment capital. ′′ Black Rock ′′ is also (by chance) the main shareholder of MICROSOFT, owned by Bill Gates, who (by chance) shares Pfizer (which - remember? She sells miraculous) and (by chance) is now a sponsor for WHO.

    #soros
    #pandemic
    #wuhan
    #covid
    #vaccine
    #vaxx
    #blackrock
    #WHO
    #pfizer
    #billgates
    #fauci
    #globacide
    Following the money... The Wuhan Chinese biological laboratory is owned by GlaxoSmithKline, which (by chance) also owns Pfizer. GlaxoSmithKline (accidentally) is controlled by Black Rock's financial department, which (accidentally) addresses the finances of Open Foundation Company (Soros Foundation), which (by accident) french manages AXA. Soros (accidentally) is the owner of the German Winterthur company that (accidentally) built a Chinese laboratory in Wuhan and bought by German Alliance, whose (accidentally) Vanguard is (by chance) is the shareholder of Black Rock, which (by chance) checks the central banks and manages about a third of global investment capital. ′′ Black Rock ′′ is also (by chance) the main shareholder of MICROSOFT, owned by Bill Gates, who (by chance) shares Pfizer (which - remember? She sells miraculous) and (by chance) is now a sponsor for WHO. #soros #pandemic #wuhan #covid #vaccine #vaxx #blackrock #WHO #pfizer #billgates #fauci #globacide
    0 Comments 0 Shares 561 Views
  • THE SNAKES ARE COMING OUT

    The masks begin to fall off ! *“The Chinese biological laboratory in Wuhan is owned by GlaxoSmithKline, which (accidentally) owns Pfizer!”* (the one who makes the vaccine against the virus which (accidentally) started at the Wuhan Biological Lab and which was (accidentally) funded by Dr. Fauci, who (accidentally) promotes the vaccine !

    *"GlaxoSmithKline is (accidentally) managed by the finance division of Black Rock, which (accidentally) manages the finances of the Open Foundation Company (Soros Foundation), which (accidentally) manages the French AXA !”*

    Soros (accidentally) owns the German company Winterthur, which (accidentally) built a Chinese laboratory in Wuhan and was bought by the German Allianz, which (coincidentally) has Vanguard as a shareholder, who (coincidentally) is a shareholder of Black Rock, which (coincidentally) controls central banks and manages about a third of global investment capital. “Black Rock" is also (coincidentally) a major shareholder of MICROSOFT, owned by Bill Gates, who (coincidentally) is a shareholder of Pfizer (which - remember ? sells a miracle vaccine) and (coincidentally) is now the first sponsor of the WHO !

    Now you understand how a dead bat sold in a wet market in China has infected the WHOLE PLANET !""

    Now you know pass it on until whole world knows.

    THOUGHTS?


    Join @QNewsOfficialTV
    💥THE SNAKES ARE COMING OUT💥 The masks begin to fall off ! *“The Chinese biological laboratory in Wuhan is owned by GlaxoSmithKline, which (accidentally) owns Pfizer!”* (the one who makes the vaccine against the virus which (accidentally) started at the Wuhan Biological Lab and which was (accidentally) funded by Dr. Fauci, who (accidentally) promotes the vaccine ! *"GlaxoSmithKline is (accidentally) managed by the finance division of Black Rock, which (accidentally) manages the finances of the Open Foundation Company (Soros Foundation), which (accidentally) manages the French AXA !”* Soros (accidentally) owns the German company Winterthur, which (accidentally) built a Chinese laboratory in Wuhan and was bought by the German Allianz, which (coincidentally) has Vanguard as a shareholder, who (coincidentally) is a shareholder of Black Rock, which (coincidentally) controls central banks and manages about a third of global investment capital. “Black Rock" is also (coincidentally) a major shareholder of MICROSOFT, owned by Bill Gates, who (coincidentally) is a shareholder of Pfizer (which - remember ? sells a miracle vaccine) and (coincidentally) is now the first sponsor of the WHO ! Now you understand how a dead bat sold in a wet market in China has infected the WHOLE PLANET !"" Now you know pass it on until whole world knows. THOUGHTS? Join @QNewsOfficialTV
    Like
    2
    0 Comments 0 Shares 417 Views
  • [Forwarded from Freedom Warriors (Shillitz)]
    THE SNAKES ARE COMING OUT.

    The masks begin to fall off ! “The Chinese biological laboratory in Wuhan is owned by GlaxoSmithKline, which (accidentally) owns Pfizer!” (the one who makes the vaccine against the virus which (accidentally) started at the Wuhan Biological Lab and which was (accidentally) funded by Dr. Fauci, who (accidentally) promotes the vaccine !

    "GlaxoSmithKline is (accidentally) managed by the finance division of Black Rock, which (accidentally) manages the finances of the Open Foundation Company (Soros Foundation), which (accidentally) manages the French AXA !”

    Soros (accidentally) owns the German company Winterthur, which (accidentally) built a Chinese laboratory in Wuhan and was bought by the German Allianz, which (coincidentally) has Vanguard as a shareholder, who (coincidentally) is a shareholder of Black Rock, which (coincidentally) controls central banks and manages about a third of global investment capital. “Black Rock" is also (coincidentally) a major shareholder of MICROSOFT, owned by Bill Gates, who (coincidentally) is a shareholder of Pfizer (which - remember ? sells a miracle vaccine) and (coincidentally) is now the first sponsor of the WHO !

    Now you understand how a dead bat sold in a wet market in China has infected the WHOLE PLANET !""

    Now you know pass it on until whole world knows.
    [Forwarded from Freedom Warriors (Shillitz)] THE SNAKES ARE COMING OUT. The masks begin to fall off ! “The Chinese biological laboratory in Wuhan is owned by GlaxoSmithKline, which (accidentally) owns Pfizer!” (the one who makes the vaccine against the virus which (accidentally) started at the Wuhan Biological Lab and which was (accidentally) funded by Dr. Fauci, who (accidentally) promotes the vaccine ! "GlaxoSmithKline is (accidentally) managed by the finance division of Black Rock, which (accidentally) manages the finances of the Open Foundation Company (Soros Foundation), which (accidentally) manages the French AXA !” Soros (accidentally) owns the German company Winterthur, which (accidentally) built a Chinese laboratory in Wuhan and was bought by the German Allianz, which (coincidentally) has Vanguard as a shareholder, who (coincidentally) is a shareholder of Black Rock, which (coincidentally) controls central banks and manages about a third of global investment capital. “Black Rock" is also (coincidentally) a major shareholder of MICROSOFT, owned by Bill Gates, who (coincidentally) is a shareholder of Pfizer (which - remember ? sells a miracle vaccine) and (coincidentally) is now the first sponsor of the WHO ! Now you understand how a dead bat sold in a wet market in China has infected the WHOLE PLANET !"" Now you know pass it on until whole world knows.
    0 Comments 0 Shares 415 Views
  • The cookie crumbles And so the cookie starts to crumble... Daylight killers... The masks begin to fall off! "The Chinese biological laboratory in Wuhan is owned by Glaxosmithkline, which (accidentally) owns Pfizer!" (the one who makes the vaccine against the virus which was (accidentally) started at the Wuhan Biological Lab and which was (accidentally) funded by Dr. Fauci, who (accidentally) promotes the vaccine! "GlaxoSmithKline is (accidentally) managed by the finance division of Black Rock, which (accidentally) manages the finances of the Open Foundation Company (Soros Foundation), which (accidentally) manages the French AXA! "Soros (accidentally) owns the German company Winterthur, which (accidentally) built a Chinese laboratory in Wuhan and was bought by the German Allianz, which (coincidentally) has Vanguard as a shareholder, who (coincidentally) is a shareholder of Black Rock," which (coincidentally) controls central banks and manages about a third of global investment capital. "Black Rock" is also (coincidentally) a major shareholder of MICROSOFT, owned by Bill Gates, who (coincidentally) is a shareholder of Pfizer (which - remember? Sells a miracle vaccine) and (coincidentally) is now the first sponsor of the 'WHO! Now you understand how a dead bat sold in a wet market in China has infected the WHOLE PLANET! "" Share quickly
    The cookie crumbles And so the cookie starts to crumble... Daylight killers... The masks begin to fall off! "The Chinese biological laboratory in Wuhan is owned by Glaxosmithkline, which (accidentally) owns Pfizer!" (the one who makes the vaccine against the virus which was (accidentally) started at the Wuhan Biological Lab and which was (accidentally) funded by Dr. Fauci, who (accidentally) promotes the vaccine! "GlaxoSmithKline is (accidentally) managed by the finance division of Black Rock, which (accidentally) manages the finances of the Open Foundation Company (Soros Foundation), which (accidentally) manages the French AXA! "Soros (accidentally) owns the German company Winterthur, which (accidentally) built a Chinese laboratory in Wuhan and was bought by the German Allianz, which (coincidentally) has Vanguard as a shareholder, who (coincidentally) is a shareholder of Black Rock," which (coincidentally) controls central banks and manages about a third of global investment capital. "Black Rock" is also (coincidentally) a major shareholder of MICROSOFT, owned by Bill Gates, who (coincidentally) is a shareholder of Pfizer (which - remember? Sells a miracle vaccine) and (coincidentally) is now the first sponsor of the 'WHO! Now you understand how a dead bat sold in a wet market in China has infected the WHOLE PLANET! "" Share quickly
    Like
    1
    0 Comments 0 Shares 427 Views
  • SHARE FAR AND WIDE The Chinese biological laboratory in Wuhan is owned by Glaxosmithkline who (by coincidence) owns Pfizer!
    (The one who produces the vaccine for the virus that (by coincidence) started in the biological laboratory in Wuhan, which (by coincidence) was funded by Dr. Fauci who is (by coincidence) promoting the vaccine!)

    GlaxoSmithKline (by coincidence) is managed by Black Rock finances who (by coincidence) manages the finances of the Open Foundation Company (Soros Foundation) which (by coincidence) serves the French AXA!

    By coincidence Soros owns the German company Winterthur which (by coincidence) built the Chinese laboratory in Wuhan and was bought by the German Allianz which (by coincidence) has Vanguard as a shareholder which (by coincidence) is a shareholder of Black Rock, which (by coincidence) controls the central banks and manages about one third of the global investment capital.

    Black Rock (by coincidence) is also a major shareholder of MICROSOFT, the property of Bill Gates, who (by coincidence) is a shareholder of Pfizer (selling the miracle Vaccine) and (by coincidence) is currently the first sponsor of WHO...

    Please fact check and share...
    SHARE FAR AND WIDE The Chinese biological laboratory in Wuhan is owned by Glaxosmithkline who (by coincidence) owns Pfizer! (The one who produces the vaccine for the virus that (by coincidence) started in the biological laboratory in Wuhan, which (by coincidence) was funded by Dr. Fauci who is (by coincidence) promoting the vaccine!) GlaxoSmithKline (by coincidence) is managed by Black Rock finances who (by coincidence) manages the finances of the Open Foundation Company (Soros Foundation) which (by coincidence) serves the French AXA! By coincidence Soros owns the German company Winterthur which (by coincidence) built the Chinese laboratory in Wuhan and was bought by the German Allianz which (by coincidence) has Vanguard as a shareholder which (by coincidence) is a shareholder of Black Rock, which (by coincidence) controls the central banks and manages about one third of the global investment capital. Black Rock (by coincidence) is also a major shareholder of MICROSOFT, the property of Bill Gates, who (by coincidence) is a shareholder of Pfizer (selling the miracle Vaccine) and (by coincidence) is currently the first sponsor of WHO... Please fact check and share...
    0 Comments 0 Shares 423 Views
More Results
Sponsored

We are 100% funded for October.

Thanks to everyone who helped out. 🥰

Xephula monthly operating expenses for 2024 - Server: $143/month - Backup Software: $6/month - Object Storage: $6/month - SMTP Service: $10/month - Stripe Processing Fees: ~$10/month - Total: $175/month

Xephula Funding Meter

Please Donate Here